" /> Ad5-survivin-transduced Autologous Dendritic Cell Vaccine - CISMeF





Preferred Label : Ad5-survivin-transduced Autologous Dendritic Cell Vaccine;

NCIt synonyms : Autologous Dendritic Cell Adenovirus Type 5-Survivin Vaccine; Autologous DC:AdmS; Ad5-survivin-transduced Autologous DC Vaccine;

NCIt definition : A cell-based cancer vaccine containing autologous dendritic cells (DCs) that are transduced with a replication-deficient adenovirus type 5 vector (Ad5) encoding a mutated form of the tumor-associated antigen (TAA) survivin, with potential immunostimulatory and antineoplastic activities. Upon administration, Ad5-survivin-transduced autologous DC vaccine may elicit an immune response against cancer cells expressing survivin by activating cytotoxic T-cells (CTLs). This leads to an induction of cell death in survivin-positive tumor cells. Survivin, a member of the inhibitor of apoptosis (IAP) family of proteins, may be upregulated in certain tumor cell types and plays a key role in tumor cell growth and survival.;

NCI Metathesaurus CUI : CL512260;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.